Critical Path Institute Revenue and Competitors

Catalina Foothills, AZ USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Critical Path Institute's estimated annual revenue is currently $20.3M per year.(i)
  • Critical Path Institute's estimated revenue per employee is $112,200

Employee Data

  • Critical Path Institute has 181 Employees.(i)
  • Critical Path Institute grew their employee count by 20% last year.

Critical Path Institute's People

NameTitleEmail/Phone
1
Senior Advisor, Past President & CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Rare and Orphan DiseasesReveal Email/Phone
4
Director, Contracts, Legal Services, and ComplianceReveal Email/Phone
5
Executive Director, Critical Path for Parkinson'sReveal Email/Phone
6
Senior Director Predictive Analytics, Quantitative MedicineReveal Email/Phone
7
Director Regulatory ScienceReveal Email/Phone
8
Executive DirectorReveal Email/Phone
9
Associate Director, COA ProgramReveal Email/Phone
10
Associate Director, Translational Therapeutics AcceleratorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.2M675%N/AN/A
#2
$2.9M369%N/AN/A
#3
$6.7M73-4%N/AN/A
#4
$10M987%N/AN/A
#5
$19.3M17226%N/AN/A
#6
$0.5M9-10%N/AN/A
#7
$7.8M76-8%$123.4MN/A
#8
$0.1M20%N/AN/A
#9
$2.9M356%N/AN/A
#10
$4M497%N/AN/A
Add Company

What Is Critical Path Institute?

C-Path is uniquely positioned to help shorten the critical path for developing new medical products. It is an independent non-profit institute, unaffiliated with any single entity or interest group, created in 2005 by the University of Arizona and the U.S. Food and Drug Administration (FDA). Its neutral status allows C-Path to serve as an effective and welcome facilitator among scientists from the government, academia and the private sectors.

keywords:N/A

N/A

Total Funding

181

Number of Employees

$20.3M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Critical Path Institute News

2022-04-06 - EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

Critical Path Institute's (C-Path) Type 1 Diabetes Consortium (T1DC) today announced that the European Medicines Agency (EMA) has issued a...

2022-04-06 - Could computer models be the key to better COVID vaccines?

So, most vaccine companies simply made what Jeff Barrett, a quantitative pharmacologist at the Critical Path Institute, a non-profit...

2022-04-06 - Cutting-Edge Research Reveals Greater Insights into ...

The WATCH-PD study is part of the Critical Path Institute's 3DT and Parkinson's initiatives and provides preliminary support for the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$53.7M22225%N/A
#2
$115.1M34110%N/A
#3
$121.2M35910%N/A
#4
$168.6M860N/AN/A
#5
$230.4M10971%N/A